These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6097272)

  • 21. Effect of peptidase inhibitors on [Met5]enkephalin-Arg6-Phe7 and [Met5]enkephalin-Arg6-Gly7-Leu8-induced antinociception.
    Mellstrom B; Iadarola MJ; Costa E
    Eur J Pharmacol; 1987 Jan; 133(2):185-90. PubMed ID: 2949992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the novel compound, Hoe 065, upon impaired learning and memory in rodents.
    Hock FJ; Gerhards HJ; Wiemer G; Stechl J; Rüger W; Urbach H
    Eur J Pharmacol; 1989 Nov; 171(1):79-85. PubMed ID: 2612569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension.
    Karlberg BE; Lindström T; Rosenqvist U; Ohman KP
    Am J Cardiol; 1987 Apr; 59(10):104D-109D. PubMed ID: 3034016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension.
    Stumpe KO; Overlack A; Kolloch R; Schatz J; Witte PU; Pahnke K
    Klin Wochenschr; 1986 Jun; 64(12):558-62. PubMed ID: 3016405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase.
    Mellstrom B; Iadarola MJ; Yang HY; Costa E
    J Pharmacol Exp Ther; 1986 Oct; 239(1):174-8. PubMed ID: 2945003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal man.
    Malatino LS; Manhem P; Ball SG; Leckie BJ; Morton JJ; Murray GD; Robertson JI
    J Clin Hypertens; 1986 Sep; 2(3):231-7. PubMed ID: 3023553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of a novel orally active angiotensin converting enzyme inhibitor (HOE 498) in healthy subjects.
    Witte PU; Irmisch R; Hajdú P; Metzger H
    Eur J Clin Pharmacol; 1984; 27(5):577-81. PubMed ID: 6097458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV).
    Gerckens U; Grube E; Mengden T; Sigel H; Wagner WL; Lahn T; Irmisch R; Metzger H
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S49-51. PubMed ID: 2474102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure response of nephrectomized subjects and patients with essential hypertension to ramipril: indirect evidence that inhibition of tissue angiotensin converting enzyme is important.
    Wenting GJ; Blankestijn PJ; Poldermans D; van Geelen J; Derkx FH; Man in't Veld AJ; Schalekamp MA
    Am J Cardiol; 1987 Apr; 59(10):92D-97D. PubMed ID: 3034041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic, pharmacokinetic and humoral effects of oral zabicipril, an angiotensin converting enzyme inhibitor in normotensive man.
    MacDonald NJ; Hughes DM; Lees KR; Reid JL
    Br J Clin Pharmacol; 1990 Jul; 30(1):107-13. PubMed ID: 2202384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baroreflex setting and sensitivity in normal subjects: effects of pharmacologic inhibition of the angiotensin I converting enzyme.
    Düsing R; Kayser G; Wagner S; Scherf H; Glänzer K; Predel HG; Kramer HJ
    Am J Cardiol; 1987 Apr; 59(10):50D-54D. PubMed ID: 3034033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics, converting enzyme inhibition and peripheral arterial hemodynamics of ramipril in healthy volunteers.
    Thuillez C; Richer C; Giudicelli JF
    Am J Cardiol; 1987 Apr; 59(10):38D-44D. PubMed ID: 3034032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unchanged pressor effect of norepinephrine in normal man following the oral administration of two angiotensin converting enzyme inhibitors, captopril and HOE 498.
    Vierhapper H; Witte PU; Waldhäusl W
    J Hypertens; 1986 Feb; 4(1):9-11. PubMed ID: 3007605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of ramipril in renal failure.
    Aurell M; Delin K; Herlitz H; Ljungman S; Witte PU; Irmisch R
    Am J Cardiol; 1987 Apr; 59(10):65D-69D. PubMed ID: 3034036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of renal function on the pharmacokinetics of ramipril (HOE 498).
    Debusmann ER; Pujadas JO; Lahn W; Irmisch R; Jané F; Kuan TS; Mora J; Walter U; Eckert HG; Hajdú P
    Am J Cardiol; 1987 Apr; 59(10):70D-78D. PubMed ID: 3034037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
    Clauser E
    Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
    Becker RH; Baldes L; Treudler M
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical performance during sustained converting enzyme inhibition with Hoe 498 in conscious dogs.
    Becker RH; Fieber P; Schulze KJ
    Arch Int Pharmacodyn Ther; 1985 Dec; 278(2):303-13. PubMed ID: 3006617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human intestinal brush border angiotensin-converting enzyme activity and its inhibition by antihypertensive Ramipril.
    Stevens BR; Fernandez A; Kneer C; Cerda JJ; Phillips MI; Woodward ER
    Gastroenterology; 1988 Apr; 94(4):942-7. PubMed ID: 2831105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.